Efficacy of Isa-Pom-Dex Therapy in Double Refractory Multiple Myeloma (MM) Patients in Real Clinical Practice

Maxim Soloviev(National Medical Research Center for Hematology), Н. В. Медведева(City Clinical Hospital No 31), Т. И. Поспелова, Maiia Soloveva(Ministry of Health of the Russian Federation), Г. А. Дудина(Moscow Clinical Scientific Center), Marina Demchenkova(Irkutsk Regional Clinical Hospital), Anna Kopylova, А Д Гарифуллин(Russian Research Institute of Hematology and Transfusiology), Tatyana Tsyganok(Sakhalin State University), Evgenia Zhelnova(City Clinical Hospital), Sergey Voloshin(Russian Research Institute of Hematology and Transfusiology), Galina Kuchma(Orenburg State Medical Academy), Marina Zakharova(City Clinical Hospital), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), M. G. Kiseleva, A. Yu. Chuprakova, Т. И. Ольховик(Krasnoyarsk Regional Clinical Hospital), Viktoria Ryabchikova(City Clinical Hospital No 31), Elena Volodicheva, Е. Г. Кириллова, Т. А. Митина(Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky), Anastasia Semenova(Ministry of Health of the Russian Federation), Yulia Gammershmidt, Varvara Bahtina(Krasnoyarsk Regional Clinical Hospital), Наталья Николаевна Скворцова(Novosibirsk State University), I. S. Usankin(Children's City Clinical Hospital №11), Oksana Ochirova(Ulyanovsk Regional Clinical Hospital), N. R. Solovkova(Irkutsk Regional Clinical Hospital)
Blood
November 5, 2024
Cited by 1


Related Papers